← Leaderboards
Matthew Frank Kalady
Duke University
$1,849,540
Attributed
$1,849,540
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $362.6K · FY2015–19$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$1,849,540 · 2
By mechanism
R01$1,800,943 · 1
F32$48,597 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Johannes W.g. Vieweg$4,142,091
- Eli Gilboa$17,521,988
- Matthew J Ellis$25,349,408
- Herbert Kim Lyerly$48,598,090
- Shiaowen David Hsu$2,914,269
Others in their field
Top investigators on “Colorectal Cancer”
- Norman Wolmark · Nsabp Foundation, Inc.$253,344,814
- Joseph P. Costantino · University Of Pittsburgh At Pittsburgh$72,920,401
- William J. Blot · Vanderbilt University$60,929,890
- Loic Le Marchand · University Of Hawaii At Manoa$57,327,999
- Ulrike Peters · Fred Hutchinson Cancer Research Center$56,201,247
- Andrew T Chan · Massachusetts General Hospital$47,099,005
Research focus
Colorectal CancerCombined Modality TherapyAdjuvant ChemotherapyAutomobile DrivingAnti-InflammatoryBiological MarkersAntibodiesCancer EtiologyCancer InitiationCancer ModelBaseCell MaintenanceCell ProliferationCellsCell SurvivalCancer CellCessation Of LifeCharacteristicsChemotherapyClinically RelevantClinical TrialsColonColon Cancer PatientsComplex
Grant awards (8)
Microenvironment Interleukin-17 and Colorectal Cancer Treatment Resistance$286,826
R01 · FY2019 · CA · contact PI
Microenvironment Interleukin-17 and Colorectal Cancer Treatment Resistance$63,841
R01 · FY2019 · CA · contact PI
Microenvironment Interleukin-17 and Colorectal Cancer Treatment Resistance$362,569
R01 · FY2018 · CA · contact PI
Microenvironment Interleukin-17 and Colorectal Cancer Treatment Resistance$362,569
R01 · FY2017 · CA · contact PI
Microenvironment Interleukin-17 and Colorectal Cancer Treatment Resistance$362,569
R01 · FY2016 · CA · contact PI
Microenvironment Interleukin-17 and Colorectal Cancer Treatment Resistance$362,569
R01 · FY2015 · CA · contact PI
RNA pulsed Dendritic Cells as Immunotherapy for Melanoma$8,401
F32 · FY2002 · CA
RNA pulsed Dendritic Cells as Immunotherapy for Melanoma$40,196
F32 · FY2001 · CA